Universal test and treat not enough to end HIV epidemic
OUTPUT TYPE: Journal Article
PUBLICATION YEAR: 2021
TITLE AUTHOR(S): A.Teagle
KEYWORDS: ANTIRETROVIRAL THERAPY (ART), HIV/AIDS, SUB-SAHARAN AFRICA, SWAZILAND
DEPARTMENT: Impact Centre (IC), Impact Centre (PRESS), Impact Centre (CC)
Web link: http://www.hsrc.ac.za/en/review/hsrc-review-dec-2021/universal-test-not-enough-to-end-hiv-pandemic
Print: HSRC Library: shelf number 12861
HANDLE: 20.500.11910/19079
URI: http://hdl.handle.net/20.500.11910/19079
If you would like to obtain a copy of this Research Output, please contact Hanlie Baudin at researchoutputs@hsrc.ac.za.
Abstract
Early models of HIV epidemics calculated that near-universal antiretroviral treatment coverage and medical circumcision could almost eliminate new infections. However, as countries like Eswatini reach their 90-90-90 targets, it's becoming clear that this is not the case. Randomised trials in sub-Saharan Africa confirm the feasibility of universal test-and-treat, but localised data and additional preventative measures are needed to reduce new infections enough to eliminate the HIV epidemic.-
Related Research Outputs:
- Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017
- Dynamics of HIV epidemic in Sub-Saharan Africa: who are we leaving behind in treatment?
- Maternal factors associated with infant neurodevelopment in HIV-exposed uninfected infants
- Adolescent human immunodeficiency virus self-management: associations with treatment adherence, viral suppression, sexual risk behaviours and health-related quality of life
- Lottery incentives have short-term impact on ART initiation among men: results from a randomized pilot study
- PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study
- Data driven HIV programming to maximise health benefits
- Towards achieving the 90-90-90 HIV targets: results from the South African 2017 national HIV survey
- HIV drug resistance profile in South Africa: findings and implications from the 2017 national HIV household survey
- Drug-resistant HIV in South Africa: status and response
- Being ALHIV and staying alive: what do we know about adolescents living with HIV in South Africa?
- How community ART delivery may improve HIV treatment outcomes: qualitative inquiry into mechanisms of effect in a randomized trial of community-based ART initiation, monitoring and re-supply (DO ART) in South Africa and Uganda
- Socio-economic differences in the uptake of HIV testing and associated factors in South Africa
- The impact of HIV prevention interventions targeted at adolescent girls and young women (AGYW) on HIV incidence and other biomedical, behavioural, and structural outcomes in sub-Saharan Africa: a systematic review
- Association between ART adherence and mental health: results from a national HIV sero-behavioural survey in South Africa
- Understanding factors influencing utilization of HIV prevention and treatment services among patients and providers in a heterogeneous setting: a qualitative study from South Africa
- Is there risk compensation among HIV infected youth and adults 15 years and older on antiretroviral treatment in South Africa?: findings from the 2017 national HIV prevalence, incidence, behaviour and communication survey
- Secondary distribution of HIV self-testing kits to social and sexual networks of PLWH in KwaZulu-Natal, South Africa: a brief report
- Swaziland: a governance study
- Impact of HIV/AIDS on SADC countries: recommendations to funders